Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe

Cardiology

  • Home
  • Specialties
  • Cardiology
  • Page 2
Oral Semaglutide and Cardiovascular Benefits in the SOUL Trial: Impact of Baseline and Changes in HbA1c and BMI on Clinical Outcomes
Posted inCardiology Diabetes & Endocrinology news

Oral Semaglutide and Cardiovascular Benefits in the SOUL Trial: Impact of Baseline and Changes in HbA1c and BMI on Clinical Outcomes

Posted by MedXY By MedXY 07/22/2026
This analysis of the SOUL trial shows oral semaglutide reduces major cardiovascular events, with greater benefits linked to higher baseline HbA1c and larger HbA1c reductions, while BMI changes did not significantly affect outcomes.
Read More
GLP-1 Receptor Agonists: A Breakthrough in Reducing Atherosclerosis and Cardiovascular Risk Beyond Diabetes and Obesity
Posted inCardiology Diabetes & Endocrinology news

GLP-1 Receptor Agonists: A Breakthrough in Reducing Atherosclerosis and Cardiovascular Risk Beyond Diabetes and Obesity

Posted by MedXY By MedXY 07/22/2026
GLP-1 receptor agonists significantly reduce atherosclerosis progression, inflammatory biomarkers, and cardiovascular events independent of glycaemic control and obesity status, evidenced by robust preclinical and large-scale clinical data.
Read More
Impact of Medically Tailored Groceries on Glycemic Control in Medicaid-Insured Adults with Type 2 Diabetes: Insights from a Randomized Controlled Trial
Posted inCardiology Clinical Updates Diabetes & Endocrinology news

Impact of Medically Tailored Groceries on Glycemic Control in Medicaid-Insured Adults with Type 2 Diabetes: Insights from a Randomized Controlled Trial

Posted by MedXY By MedXY 07/21/2026
Medically tailored groceries modestly improve HbA1c and significantly enhance food and nutrition security among Medicaid-insured adults with type 2 diabetes, supporting 'Food Is Medicine' strategies in chronic disease management.
Read More
Development and Validation of a Simplified Martin-Hopkins LDL-C Equation Using Machine Learning
Posted inCardiology news Pathology & Lab Medicine/Bệnh học

Development and Validation of a Simplified Martin-Hopkins LDL-C Equation Using Machine Learning

Posted by MedXY By MedXY 07/18/2026
This study introduces and validates a simplified machine learning-based equation for estimating LDL cholesterol, showing comparable accuracy to the original Martin-Hopkins method and improved ease of use.
Read More
Peripheral Artery Disease: Emerging Advances in Medical Therapy to Reduce Cardiovascular and Limb Risks
Posted inCardiology news

Peripheral Artery Disease: Emerging Advances in Medical Therapy to Reduce Cardiovascular and Limb Risks

Posted by MedXY By MedXY 07/18/2026
This article reviews recent advances in the medical management of peripheral artery disease, emphasizing comprehensive risk factor control, novel pharmacotherapies, and individualized approaches to improve cardiovascular and limb outcomes in affected patients.
Read More
Revolutionizing Myocardial Scar Detection: AI-Powered Contrast-Free MRI via Virtual Native Enhancement
Posted inAI Cardiology news

Revolutionizing Myocardial Scar Detection: AI-Powered Contrast-Free MRI via Virtual Native Enhancement

Posted by MedXY By MedXY 07/18/2026
A prospective multicenter study demonstrates that AI-driven virtual native enhancement (VNE) MRI can accurately detect and quantify myocardial scars without contrast agents, potentially reducing the need for gadolinium-based imaging in clinical cardiology.
Read More
Evaluating Riociguat in Early Pulmonary Vascular Disease: Insights from the ESRA Phase IIa Trial
Posted inCardiology news Respiratory

Evaluating Riociguat in Early Pulmonary Vascular Disease: Insights from the ESRA Phase IIa Trial

Posted by MedXY By MedXY 07/17/2026
The ESRA trial demonstrates that riociguat is safe and effectively reduces pulmonary vascular resistance in early pulmonary vascular disease, though secondary benefits remain unproven in this early-stage, mostly connective tissue disease-associated cohort.
Read More
Bridging the Gap: Improving Skilled Nursing Facility-to-Home Transitions for Heart Failure Patients
Posted inCardiology news

Bridging the Gap: Improving Skilled Nursing Facility-to-Home Transitions for Heart Failure Patients

Posted by MedXY By MedXY 07/16/2026
This study reveals significant gaps in discharge communication, self-care education, medication management, and follow-up coordination during skilled nursing facility-to-home transitions after heart failure hospitalization, highlighting the need for standardized workflows and enhanced cross-setting communication.
Read More
Non-HDL Cholesterol and Apolipoprotein B Measures and Risk of Atherosclerotic Cardiovascular Disease
Posted inCardiology news

Non-HDL Cholesterol and Apolipoprotein B Measures and Risk of Atherosclerotic Cardiovascular Disease

Posted by MedXY By MedXY 07/16/2026
This study compares the predictive value of non-HDL cholesterol and apolipoprotein B for atherosclerotic cardiovascular disease risk in individuals not on lipid-lowering medication.
Read More
Temporal Trends in Oral Anticoagulant Use and Clinical Outcomes Among Older Adults with Atrial Fibrillation: Insights from a Danish Nationwide Study and Contemporary Evidence
Posted inCardiology Clinical Updates news

Temporal Trends in Oral Anticoagulant Use and Clinical Outcomes Among Older Adults with Atrial Fibrillation: Insights from a Danish Nationwide Study and Contemporary Evidence

Posted by MedXY By MedXY 07/16/2026
Recent decades saw increased anticoagulant use and reduced stroke risk in elderly AF patients, especially with DOACs, but bleeding risks rise notably in very elderly patients, highlighting tailored management needs.
Read More
Coronary Artery Calcium and Statin Allocation in the Era of PREVENT: Evidence from MESA
Posted inCardiology news

Coronary Artery Calcium and Statin Allocation in the Era of PREVENT: Evidence from MESA

Posted by MedXY By MedXY 07/16/2026
This study assesses how coronary artery calcium (CAC) scoring refines statin eligibility using the new PREVENT risk calculator, emphasizing its value in borderline risk patients and cautioning against withholding statins solely for CAC 0 in high-risk individuals.
Read More
Hypoxia-Induced BACH1 Elevation Drives Pulmonary Hypertension via Activation of TGFBR2/SMAD Signaling
Posted inCardiology news Respiratory

Hypoxia-Induced BACH1 Elevation Drives Pulmonary Hypertension via Activation of TGFBR2/SMAD Signaling

Posted by MedXY By MedXY 07/15/2026
BACH1 stabilization under hypoxia promotes pulmonary hypertension by enhancing TGFBR2/SMAD pathway activity in pulmonary artery smooth muscle cells, suggesting BACH1 as a promising therapeutic target for PH.
Read More
Molecular Mutations and Cardiovascular Risks Shape Prognosis in Triple-Negative Essential Thrombocythemia
Posted inCardiology Hematology-Oncology news

Molecular Mutations and Cardiovascular Risks Shape Prognosis in Triple-Negative Essential Thrombocythemia

Posted by MedXY By MedXY 07/15/2026
This study reveals that specific gene mutations and cardiovascular risk factors significantly influence prognosis and thrombotic risk in triple-negative essential thrombocythemia, highlighting the importance of molecular profiling for personalized treatment.
Read More
HERZCHECK: Revolutionizing Early Detection of Subclinical Preheart Failure in Rural Regions via Mobile Cardiac MRI and Telemedicine
Posted inCardiology news

HERZCHECK: Revolutionizing Early Detection of Subclinical Preheart Failure in Rural Regions via Mobile Cardiac MRI and Telemedicine

Posted by MedXY By MedXY 07/14/2026
HERZCHECK demonstrates that mobile, telemedically supervised cardiac MRI enables early detection of subclinical preheart failure in at-risk individuals with cardiovascular risk factors in rural areas, identifying disease nearly seven years before symptomatic heart failure develops.
Read More
Maternal Diabetes and the Elevated Risk of Early-Onset Cardiovascular Disease in Offspring: Insights from a Swedish Nationwide Cohort Study
Posted inCardiology news OB/GYN & Women’s Health

Maternal Diabetes and the Elevated Risk of Early-Onset Cardiovascular Disease in Offspring: Insights from a Swedish Nationwide Cohort Study

Posted by MedXY By MedXY 07/14/2026
A comprehensive nationwide study reveals that maternal diabetes during pregnancy, particularly pregestational diabetes, significantly increases offspring's risk of early-onset cardiovascular diseases, mediated partly by perinatal complications.
Read More
Wine Consumption, Mediterranean Diet, and Cardiovascular Risk in Two Spanish Cohorts
Posted inCardiology news Public Health

Wine Consumption, Mediterranean Diet, and Cardiovascular Risk in Two Spanish Cohorts

Posted by MedXY By MedXY 07/14/2026
This study from two Spanish cohorts explores how moderate wine consumption within a Mediterranean diet impacts cardiovascular disease and mortality, suggesting modest benefits but advising cautious interpretation.
Read More
ORBITA-CTO Trial: Evaluating the Impact of Percutaneous Coronary Intervention on Symptomatic Chronic Total Occlusion in Stable Angina
Posted inCardiology news

ORBITA-CTO Trial: Evaluating the Impact of Percutaneous Coronary Intervention on Symptomatic Chronic Total Occlusion in Stable Angina

Posted by MedXY By MedXY 07/14/2026
The ORBITA-CTO multicenter, randomized, placebo-controlled trial demonstrates that PCI significantly improves angina symptoms and quality of life in patients with single-vessel CTO without bystander disease, compared to placebo.
Read More
Microplastic Exposure and Cardiomyopathy: Unveiling the Gut-Heart Axis Mechanism
Posted inCardiology Gastroenterology news

Microplastic Exposure and Cardiomyopathy: Unveiling the Gut-Heart Axis Mechanism

Posted by MedXY By MedXY 07/14/2026
This study reveals that bisphenol F exposure aggravates cardiomyopathy under hemodynamic stress through gut microbiota metabolism, highlighting a novel gut-heart axis involving N-acetylputrescine and potential therapeutic targets.
Read More
Cardiac Alterations in Swimming-Induced Pulmonary Edema: Clinical Implications for Acute Evaluation
Posted inCardiology news Respiratory

Cardiac Alterations in Swimming-Induced Pulmonary Edema: Clinical Implications for Acute Evaluation

Posted by MedXY By MedXY 07/13/2026
A cohort study reveals that swimming-induced pulmonary edema (SIPE) is associated with transient mild cardiac dysfunction and elevated biomarkers, distinguishing it from asymptomatic swimmers and guiding acute assessment strategies.
Read More
Timing Matters: How Premeal Insulin Enhances Postprandial Glucose Control and Myocardial Microvascular Blood Flow in Type 1 Diabetes
Posted inCardiology Diabetes & Endocrinology news

Timing Matters: How Premeal Insulin Enhances Postprandial Glucose Control and Myocardial Microvascular Blood Flow in Type 1 Diabetes

Posted by MedXY By MedXY 07/13/2026
Premeal insulin administration significantly lowers postprandial blood glucose and improves myocardial microvascular blood flow in young adults with type 1 diabetes, highlighting the importance of insulin timing for cardiovascular health.
Read More

Posts pagination

Previous page 1 2 3 4 … 59 Next page
  • Comparative Diagnostic Accuracy of RIPASA and Modified Alvarado Scores in Acute Appendicitis: Insights from an Indian Tertiary Centre
  • Rethinking Race/Ethnicity in Cardiovascular Risk Assessment: The Race-Free MESA Risk Score
  • Evaluating LACE and HOSPITAL Scores for Predicting 30-day Readmissions in a Pakistani Tertiary Care Setting
  • Unveiling BPNT1 Mutations as a Novel Cause of Vitamin B12-Dependent Megaloblastic Anemia
  • Surface Topographic Assessment of Forced Pulmonary Maneuvers: Reliability and Agreement with Spirometry in Healthy Participants
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology health heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation MASLD mental health metformin Mortality myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prostate cancer public health quality of life randomized clinical trial randomized controlled trial randomized trial risk stratification SGLT2 inhibitors stroke type 1 diabetes type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top
Sign in